Open Access

T cells and reactive oxygen species

Journal of Biomedical Science201522:85

https://doi.org/10.1186/s12929-015-0194-3

Received: 26 July 2015

Accepted: 6 October 2015

Published: 15 October 2015

Abstract

Reactive oxygen species (ROS) have been long considered simply as harmful by-products of metabolism, which damage cellular proteins, lipids, and nucleic acids. ROS are also known as a weapon of phagocytes, employed against pathogens invading the host. However, during the last decade, an understanding has emerged that ROS also have important roles as signaling messengers in a multitude of pathways, in all cells, tissues, and organs. T lymphocytes are the key players of the adaptive immune response, which both coordinate other immune cells and destroy malignant and virus-infected cells. ROS have been extensively implicated in T-cell hyporesponsiveness, apoptosis, and activation. It has also become evident that the source, the kinetics, and the localization of ROS production all influence cell responses. Thus, the characterization of the precise mechanisms by which ROS are involved in the regulation of T-cell functions is important for our understanding of the immune response and for the development of new therapeutic treatments against immune-mediated diseases. This review summarizes the 30-year-long history of research on ROS in T lymphocytes, with the emphasis on the physiological roles of ROS.

Keywords

T lymphocytes ROS Oxidative stress Hyporesponsiveness AICD Apoptosis Activation Differentiation Signaling TCR

Introduction to ROS

ROS are small short-lived oxygen-containing molecules that are chemically highly reactive, a property that is mainly due to their unpaired electrons (radicals). Superoxide (O2 •−), hydrogen peroxide (H2O2), hydroxyl radical (OH), hypochlorous acid (HOCl), lipid peroxides (ROOH), singlet oxygen (1O2), and ozone (O3) are some of the most common ROS [1]. The first two species are the most important ROS involved in the regulation of biological processes. O2 •− is usually the species from which other ROS originate. Once produced, O2 •− either rapidly reacts with surrounding molecules or dismutates to H2O2, spontaneously or with the help of superoxide dismutase (SOD) [2]. H2O2 is more stable, less reactive, can diffuse in the microenvironment and even cross cell membranes. H2O2 can either react with particular amino acids, usually cysteines and methionines, or can be converted to OH (in the Fenton reaction), HOCl (by myeloperoxidase), or H2O (with the help of catalase, peroxidase, or peroxiredoxin) [3]. Both OH and HOCl are highly reactive and usually irreversibly damage nearby molecules.

One of the major sources of ROS in the cell are mitochondria [4, 5]. Mitochondria express the electron transport chain (ETC.) complexes, which transfer electrons from NADH and succinate, along a controlled redox pathway, to the oxygen molecule (O2). Upon receiving four electrons, O2 is reduced to H2O. However, the ETC is not perfect, and occasionally O2 undergoes one- or two-electron reduction to form O2 •− or H2O2, respectively. Complexes I and III of the ETC are the main sources of mitochondrial O2 •− [4, 5]. Multiple metabolic enzymes, such as ERO-1, cytochromes P-450 and b5, lipoxygenases, cyclooxygenases, α-ketoglutarate- and glycerol phosphate dehydrogenases, as well as hydroxyacid-, urate-, xanthine-, monoamine-, diamine-, polyamine-, and amino acid oxidases, are also producing ROS as necessary intermediates or byproducts of their reactions [6]. These enzymes can be found in mitochondria, endoplasmic reticulum, peroxisomes, and cytosol. There is also a large class of ROS producing enzymes called NADPH oxidases (see below). Finally, there are exogenous sources of ROS, including ultraviolet and gamma radiation, smoke and other air pollutants, as well as several drugs and chemicals. As ROS can damage proteins, lipids, and nucleic acids, the evolution has created specialized antioxidant systems. There are antioxidant enzymes, such as SODs, catalases, glutathione peroxidases (GPXs), peroxiredoxins (PRXs), thioredoxins (TRXs), glutaredoxins (GRXs), sulfiredoxins (SRXs), thioredoxin reductases, glutathione reductases, and methionine sulfoxide reductases [7], and also small nonenzymatic antioxidant molecules, such as glutathione, ascorbate, pyruvate, α-ketoglutarate, and oxaloacetate [8]. When the rate of ROS production in the cell (or in the microenvironment) significantly exceeds the rate of their neutralization by the antioxidant systems, the cell undergoes oxidative stress. Prolonged or excessive oxidative stress can lead to the impairment of cellular functions, cell death, senescence, or malignant transformation [911].

Phagocytic cells produce ROS to kill engulfed bacteria during the so-called respiratory burst [12]. In these cells, ROS are produced by the phagocytic NADPH oxidase (PHOX), an enzyme consisting of several subunits [13]. The catalytic subunit, called the PHOX glycoprotein of 91 kDa (gp91phox) or the NADPH oxidase 2 (NOX-2), is expressed at either the plasma or phagosomal membrane. PHOX includes also a variety of regulatory subunits: membrane-anchored p22phox and cytoplasmic p40phox, p47phox, and p67phox, as well as the RAC GTPase. PHOX becomes functional upon the tightly regulated assembly of this multisubunit complex. Interestingly, six homologs of gp91phox (NOX-2) have been identified in different tissues: NOX-1, NOX-3, NOX-4, NOX-5, dual oxidase 1 (DUOX-1), and DUOX-2 [14, 15]. NOXs are usually activated upon the triggering of cell receptors by their respective ligands, such as insulin, angiotensin, PDGF, GM-CSF, TNF, chemokines that bind G protein-coupled receptors, complement component 5a (C5a), lysophospholipids, and leukotriene B4, as well as by cell adhesion and by phagocytosis [8]. Because of the widespread yet differential expression of NOX and DUOX isoforms across organelles, cell types, and organisms, O2 •− and H2O2 can be considered as ubiquitous signaling messengers. Indeed, during the last decade, it has become evident that ROS are not just harmful byproducts of metabolism and weapons of phagocytes but are also crucial players in cellular signaling. ROS-mediated signaling is involved in multiple processes, such as cell growth [14, 15], stem cell renewal [16, 17], tumorigenesis [8, 14, 17], cell death [14, 15], cell senescence [15, 17], cell migration [16], oxygen sensing [15], angiogenesis [15], circadian rhythm maintenance [16], and immune responses [8, 15].

Among ROS, H2O2 acts as the major signaling messenger and is excellently suited for this function [18]. In fact, it is stable enough, is able to cross cell membranes, and is reacting preferentially with cysteine residues [3]. It has to be noted that cysteine residues are amongst the most conserved and least abundant protein residues [19], which ensures high selectivity and specificity for oxidation-mediated post-translational modifications. Moreover, only specific cysteinyl thiols that, upon coordination with neighboring amino acid side chains, can become thiolate anions are able to react with H2O2 [20]. When H2O2 oxidizes a cysteine thiolate anion (R-S), sulfenic acid (R-SOH) is formed [21, 22]. This process, which is referred to as sulfenylation, is reversed by GRXs and TRXs [7, 20]. Thus, sulfenylation is believed to be akin to phosphorylation or other post-translational modifications. Sulfenylation may lead to further post-translational modifications, such as glutathionylation, disulfide bond formation, and sulfinilation [21, 22]. Most importantly, it can be involved in the regulation of protein activity. In fact, sulfenylation can induce changes in the protein conformation, thus leading to the activation or inactivation of the catalytic center or to other functional alterations of the protein. Multiple protein classes have been shown to be regulated by sulfenylation, including phosphatases and kinases, transcription factors and histone deacetylases, antioxidant enzymes and heat-shock proteins, proteases and hydrolases, ion channels and pumps, adaptor molecules and cytoskeleton components [8, 16, 17, 2123].

It is believed that the NOX enzymes are the major source of signaling ROS [24]. Nevertheless, it is likely that ROS produced by the mitochondrial ETC or metabolic enzymes are also involved in signaling processes [2528]. The levels of ROS that are involved in signal transduction are much lower than the levels occurring during respiratory burst or oxidative stress. Moreover, due to the abundance of antioxidant systems in the cell, ROS cannot travel long distances, and hence they transmit signals only locally, in confined compartments [29, 30]. In other words, the source and the corresponding targets of signaling ROS usually have to be in close proximity. ROS-mediated signaling can be additionally regulated via controlled alterations in local levels and activity of specific antioxidants [16, 23]. For example, glutathione is a good scavenger for many ROS, such as HOCl, but reacts too slowly with H2O2, the major mediator of oxidative signaling. On the contrary, PRXs have remarkably high reaction rates with H2O2, and their activity is tightly regulated by phosphorylation and sulfinilation. In fact, PRXs appear to be the major scavengers of signaling ROS, akin to phosphatases in the kinase-phosphatase system, and thus constitute a crucial component of redox signaling [7, 16, 23, 3134]. Moreover, some members of aquaglyceroporin and aquaporin protein families can enhance the permeability of cell membranes to H2O2, thus providing an additional level of regulation to ROS-mediated signaling [16].

Thus, the complex role of ROS in T-cell biology can be simplified by dividing it in two parts: (i) the effects of large exogenous quantities of ROS, known as oxidative stress, and (ii) the function of compartmentalized, dose- and time-controlled endogenous ROS (hereafter referred to as signaling ROS). The latter can be implicated in both the activation and the apoptosis of T cells. This review covers all three aspects of ROS involvement in T-cell functions.

Review

T cells and oxidative stress

T cells are often present in close proximity to phagocytic cells, which are known to produce large amounts of ROS during respiratory burst. Moreover, activated T cells can trigger respiratory burst by direct contacts with phagocytes [35], as well as by secreted cytokines. The phagocyte-produced ROS can reach T cells and cause oxidative stress (Fig. 1). For example, it has been shown that activated neutrophils inhibit DNA synthesis in human T cells proportionally to superoxide levels in the medium (measured by cytochrome c reduction) [36]. More importantly, the treatment with the glutathione precursor N-acetyl cysteine (NAC) or catalase prevents the inhibition [36]. Further analysis showed that this impairment of DNA synthesis is associated with alterations in the T-cell receptor (TCR) signaling, including conformational changes in TCRζ and LCK, reduced PLCγ-1 phosphorylation and calcium flux, and increased ERK phosphorylation [36]. Nevertheless, this study showed that activated neutrophils do not induce apoptosis in T cells. Interestingly, a different study demonstrated the decreased viability of human CD4+ T cells upon coculture with autologous granulocytes, which was reversed by the addition of catalase [37]. Another study attempted to mimic the effects of phagocyte-derived ROS by treating human T cells with polyamine oxidase-generated H2O2 for prolonged time [38]. This treatment suppressed the tyrosine phosphorylation, calcium flux, NFAT and NFkB (but not AP-1) activation, and IL-2 production [38]. Thus, it can be concluded from these studies that phagocyte- or, at least, neutrophil-derived ROS negatively affect T-cell signaling, activation, proliferation, and, potentially, viability. Whether this mechanism has evolved in order to prevent excessive inflammation at sites of infection is not currently known. Interestingly, to our knowledge, the direct suppression of T-cell responses by macrophage-derived ROS has not been shown yet.
Fig. 1

The redox regulation of T-cell state. Activated phagocytes produce H2O2 via NOX-2. H2O2 either oxidizes thiols (SH-) on the surface of T cells or enters inside T cells. Intracellularly, H2O2 either oxidizes glutathione (GSH) or interferes with DNA synthesis. Activated phagocytes and dendritic cells (DC) secrete cysteine (Cys) to the extracellular space. Cys is taken up by T cells and converted to GSH. GSH keeps surface thiols in the reduced state, neutralizes intracellular H2O2, and enables DNA synthesis. TCR-peptide-MHC interaction leads to the secretion of thioredoxin (TRX) by T cells, DCs, and Tregs. TRX helps to keep surface thiols in the reduced state. Black solid arrow indicates production, black dashed arrows indicate import/export, green solid arrows indicate activation, red bar-headed lines indicate inhibition.

To assess the impact of oxidative stress on T-cell viability, applications of micromolar doses of H2O2 have been performed. It appears that the susceptibility of human T cells to H2O2-induced apoptosis strongly depends on the T-cell subset. In fact, 5 μM H2O2 induces apoptosis in CD45RO+ Tmem but not in CD45RA+ Tnai cells, via the mitochondrial depolarization and caspase activation [39]. Similarly, CD4+ CD45RA+ Tnai cells are less likely to undergo cell death upon incubation with 5–20 μM H2O2 than CD4+ CD45RA Tmem cells [37]. In contrast to conventional T cells, Treg cells have lower intracellular ROS levels and are protected from H2O2-induced death [37]. Moreover, 10 μM H2O2 does not affect Treg suppressive capacity [37]. Interestingly, 100 μM H2O2 completely eliminates CD4+ T cells but has no effect on CD4+ T-cell blasts [40]. Thus, T-cell resistance to exogenous H2O2decreases in the following order: Teff > Treg > Tnai > Tmem, which may reflect the probability of a given subset to appear near ROS-producing phagocytes in an inflamed environment. It is likely that Teff cells are largely protected from ROS-mediated death and can assist phagocytes in the elimination of pathogens. However, it is unclear whether the application of a single H2O2 dose, as compared to the continuous production of ROS by phagocytes, has a physiologically meaningful effect on T cells.

Phagocytic cells regulate the redox state of the microenvironment not only by releasing ROS but also by producing antioxidants, especially the glutathione precursor cysteine (Fig. 1). In fact, activated murine macrophages secrete cysteine that can be taken up by T cells, resulting in the increased intracellular glutathione level [41]. Dendritic cells (DCs) also can secrete cysteine (Fig. 1). The LPS stimulation or the coincubation of murine DCs with T cells leads to the release of cysteine by DCs, its subsequent uptake by T cells, and conversion to glutathione [42]. This correlates with the acquisition of the reduced state by the T-cell surface thiols [42]. Human DCs also secrete cysteine, as well as thiol-reducing TRX, upon co-incubation with alloreactive T cells [43]. The coculture of antigen-pulsed human DCs with autologous T cells leads to increase in the levels of cell-surface and intracellular thiols in antigen-specific T cells and protects them from H2O2-induced apoptosis [44]. Thus, activated macrophages and DCs secrete cysteine to the extracellular space, which is taken up by T cells and converted to the antioxidant glutathione. Glutathione helps to counteract the suppressive effects of phagocyte-derived ROS. The interesting question is whether also neutrophils can release cysteine or TRX upon activation, and if not, whether this contributes to the suppressive effects of their respiratory burst on T-cells [36, 37]. It could be possible that neutrophils do not release antioxidants to maximize their antimicrobial killing capacity, during the acute phase of inflammation, whereas macrophages and DCs release cysteine to protect T-cells from ROS during antigen presentation, in late and chronic inflammation.

Interestingly, murine Tregs can suppress cysteine release by DCs, leading to the oxidation of surface thiols, decrease in intracellular glutathione, and reduction in DNA synthesis in conventional T cells [42]. The addition of exogenous cysteine partially reverts the Treg-induced inhibition of DNA synthesis in murine T cells [45]. Further experiments showed that murine Tregs suppress glutathione synthesis and cysteine release by DCs in a CTLA-4-dependent manner [45] (Fig. 1). Thus, Tregs can interfere with the cysteine release by DCs and hence allow phagocyte-derived ROS to inhibit T-cell activation. It is crucial to confirm this previously unknown mechanism of suppression in human Tregs. Interestingly, in contrast to conventional T cells, human Tregs have higher thiol content (but express similar levels of catalase, manganese SOD (MnSOD, SOD-2) and copper-zinc SOD (CuZnSOD, SOD-1)) and are more resistant to cell death induced by granulocyte-secreted H2O2 [37]. Moreover, human Tregs express and secrete more TRX-1 than conventional T cells and upregulate it stronger upon stimulation [46] (Fig. 1). Their ability to suppress T cells by contributing to the formation of an oxidative milieu is thus questionable.

Glutathione is required for DNA synthesis in murine [42, 45, 47] and human [48, 49] T cells, as well as for proper LAT conformation in human T cells [50]. It seems that particular levels of this antioxidant are required to maintain redox balance in T cells, which, in turn, appears to be indispensable for signaling and proliferation. However, it cannot be excluded that T-cell proliferation depends on some redox-unrelated functions of glutathione. Further investigation is required to distinguish between those possibilities.

Overall, under physiological conditions, there is likely an equilibrium between ROS and antioxidant systems, which is required for the proper functioning of T cells (Fig. 1). However, the perturbation of this equilibrium by changing the levels of ROS or antioxidants can result in T-cell hyper- or hyporesponsiveness, which, in turn, may lead to the development of various pathologies. For example, a genetic deficiency in ROS production by macrophages [51] or artificially increased thiol levels in T cells [52] lead to T cell-mediated arthritis upon the collagen immunization of mice. On the contrary, myeloid-derived suppressor cells, found in the majority of cancer patients, inhibit T cells by lowering the amount of cysteine released by macrophages and DCs, at least in mice [53].

ROS as regulators of activation-induced cell death

The stimulation of previously activated T cells – also called T-cell blasts – results in activation-induced cell death (AICD) [54], a process which is accompanied by the release of ROS. NOX-2, the major ROS-producing enzyme of phagocytes, has been shown to be expressed also in T-cell blasts, albeit at a very low level [55]. The same study showed that the TCR stimulation of murine T-cell blasts induces the Fas-dependent oxidation of the ROS-sensitive dye 2’,7-dichlorofluorescein diacetate (DCFDA) by NOX-2-derived ROS [55] (Fig. 2). Moreover, this stimulation also induces transient DCFDA oxidation that is not dependent on Fas or NOX-2, as well as the Fas-dependent oxidation of the superoxide-sensitive dye dihydroethidium (DHE) that is not mediated by NOX-2 [55], indicating that at least two more sources of ROS are involved in AICD. Similarly, in human T-cell blasts, TCR stimulation triggers the MEK-dependent oxidation of DHE and DCFDA [56, 57]. Moreover, TCR-triggered DCFDA oxidation in human CD4+ T-cell blasts is dependent on the DUOX-1 [58]. Other group has shown that the TCR stimulation of human T-cell blasts leads to DHE and DCFDA oxidation, FasL expression, and cell death that all depend on mitochondrial Complex I [5961]. Thus, the ligation of TCR or Fas in T-cell blasts can lead to ROS production via NOX-2, DUOX-1, mitochondria, and possibly other sources (Fig. 2). However, it remains to be shown whether human T-cell blasts produce ROS via NOX-2, and whether murine blasts produce ROS via DUOX-1 or mitochondria, upon TCR triggering.
Fig. 2

ROS in activation-induced T-cell death. TCR triggering leads to the activation of DUOX-1, which produces H2O2 that enhances the activation of ZAP-70 and the formation of the SHP-2-GAB-2-GRB-2-PLCγ-1 complex. MEK-ERK pathway increases O2 •- production by mitochondrial Complex I (CI), which leads to the expression of FasL. Superoxide dismutase (SOD), vitamin E (VitE), and glutathione (GSH) interfere with FasL expression. FasL triggers Fas that initiates apoptosis execution, further enhances O2 •- production by CI, and activates NOX-2. NOX-2 produces H2O2 that enters the cell and activates AKT but inhibits MEK. H2O2 is neutralized by peroxiredoxin (PRX) and GSH. Black solid arrows indicate production, black dashed arrow indicates import, green solid arrows indicate activation, red bar-headed lines indicate inhibition. Skull and bones indicate apoptosis

To understand the function of the different sources of ROS in T-cell blasts, RNA interference and knockout mice have been used. It has been shown that MEK and ERK activation is enhanced, whereas AKT activation is suppressed, in T-cell blasts from NOX-2-deficient mice [55] (Fig. 2). The suppression of DUOX-1 with siRNA in human CD4+ T-cell blasts leads to decrease in the ZAP-70, PLCγ-1, and ERK phosphorylation, as well as PLCγ-1, SHP-2, and GAB-2 association with GRB-2 [58] (Fig. 2). Thus, NOX-2 and DUOX-1-derived ROS are involved in TCR-mediated signaling in T-cell blasts, but their effects are different. This might be due to the different localization of NOX-2 and DUOX-1 in T cells and/or the different timing of their activation. Unfortunately, it is not possible to study the function of ROS from mitochondria by performing the knockdown of Complex I, as this will lead to the general impairment of mitochondrial function and will affect cell metabolism.

Various antioxidant compounds and the overexpression of antioxidant enzymes have also been used in order to understand the function of ROS in the signaling and the apoptosis of T-cell blasts (Fig. 2). In agreement with the results from NOX-2-deficient mice [55], both the addition of NAC and the overexpression of PRX-2 sustain MEK and ERK phosphorylation but delay AKT phosphorylation in human T-cell blasts [57]. This indicates that intracellular H2O2 is the main mediator of the observed NOX-2 effects in T-cell blasts. The overexpression of CuZnSOD or MnSOD (but not catalase or TRX peroxidase) in human T-cell blasts abrogates FasL expression [56], strengthening the evidence for mitochondrial O2 •- participation in this process [5961]. Additionally, FasL upregulation and the cell death of human T-cell blasts are prevented by NAC [59, 61] and vitamin E [62].

In summary, it seems that several different sources of ROS are involved in the AICD of T cells (Fig. 2). First, H2O2 produced by DUOX-1 upon TCR triggering serves to amplify proximal signaling events downstream of the TCR. Next, O2 •- released from mitochondrial Complex I, potentially in response to ERK signaling, triggers the expression of FasL. Finally, Fas ligation activates NOX-2, which probably assists the execution of the apoptotic program via the H2O2-mediated activation of AKT and the inhibition of MEK. Moreover, cell-intrinsic antioxidants, such as glutathione, vitamin E, MnSOD, and CuZnSOD, interfere with FasL expression, thus counteracting AICD. A better understanding of the role of ROS in the mechanisms of AICD could help in the development of therapeutic strategies for diseases in which T cells either die excessively or are not properly cleared during the contraction phase of immune response, such as AIDS or autoimmune diseases, respectively. As an example, vitamin E has already been shown to reduce FasL expression and AICD in T cells from HIV-infected patients [62].

ROS as regulators of the activation of primary T cells

There is evidence that primary human and murine T cells produce ROS upon stimulation with different agents. However, it cannot be excluded that the detected ROS originate from contaminating phagocytic cells, which are almost inevitably present in any preparation of primary T cells. Phagocytes can be activated by various agents used to stimulate T cells, for example by PMA or by anti-TCR antibodies via Fc receptors [63]. Desirably, the purity of the T-cell preparation should be very high (>99 %), and an isotype-matched control antibody should be used to discriminate between the T cell-derived ROS and the ROS of phagocytic origin. Unfortunately, these conditions have been rarely met. Moreover, activated T cells can induce respiratory burst in phagocytes by direct contacts [35], so the use of an isotype control is not the ultimate solution to this problem. Thus, the detection of specific T cell-derived ROS is a challenging task. The following paragraph summarizes data showing ROS production in primary human and murine T cells (Fig. 3).
Fig. 3

ROS in the activation of primary T cells. The ligation of CD28 leads to the activation of the lipoxygenase pathway (LOX). This enhances the expression of CD25, IL-2, and IL-4. The triggering of TCR leads to increase in O2 •- production by mitochondrial Complex III (CIII). Whether this O2 •- has any function is not clear. Additionally, the ligation of TCR leads to the activation of NOX-2, which produces H2O2 that enters the cell. Inside the cell, H2O2 activates GATA-3 and STAT-6 but inhibits STAT-3. GATA-3 and STAT-6 direct T-cell differentiation towards the Th2 phenotype and the production of IL-4 and IL-5. STAT-3 leads to differentiation into Th17 cells and to IL-17 production. Black solid arrows indicate production, black dashed arrow indicates import, green solid arrows indicate activation, red bar-headed line indicates inhibition

TCR or CD28 stimulation of human T cells induces 5-lipoxygenase-dependent DCFDA oxidation and decreases intracellular glutathione levels [64]. TCRxCD28 stimulation of human or murine T cells induces extracellular O2 •- production, measured using the luminol-based Diogenes system. O2 •- production is completely abrogated in T-cell preparations from NOX-2-deficient mice [65]. Similarly, TCR stimulation of murine CD4+ T cells induces NOX-2-dependent DCFDA oxidation [66]. Thus, these data indicate that NOX-2 is an important source of ROS in T cells. Additionally, TCR or TCRxCD28 (but not CD28) stimulation of murine CD4+ T cells induces the oxidation of the mitochondrial reduction-oxidation sensitive green fluorescent protein (mito-roGFP). Interestingly, it has been shown that the oxidation of mito-roGFP is dependent on mitochondrial calcium uptake [67]. The same study showed that TCRxCD28 stimulation induces the oxidation of the mitochondria-targeted superoxide-sensitive dye MitoSOX. This oxidation is dependent on the mitochondrial Rieske iron-sulfur protein (RISP), a subunit of Complex III [67]. CD8+ murine T cells also induce DCFDA oxidation upon TCR or CD28 stimulation [68]. Collectively, the data reported above suggest that the triggering of the TCR and CD28 in primary T cells leads to ROS production by 5-lipoxygenase, NOX-2, and mitochondria. As the majority of the studies have been in performed in murine T cells, their findings have to be confirmed in human cells. However, to ultimately solve the problem of the ROS origin, T cell-specific knockouts of NOX-2 or other ROS-producing enzymes have to be used.

T cells from mice lacking components of NOX-2, such as gp91phox or p47phox, could serve as a good model to study the function of NOX-2-derived ROS in T-cell activation. Nevertheless, results obtained using this model should be interpreted with caution, as phagocytes from these mice also lack functional NOX-2, and this may indirectly affect T cells. A T-cell specific knockout of NOX-2 will be helpful. T cells from p47phox−/− mice have the diminished expression of T-bet, STAT-1, and STAT-4 transcription factors and the lowered production of IL-2, IL-4, IFNγ, TNFα, and GM-CSF [66]. Additionally, these cells have the enhanced phosphorylation of STAT-3 and the increased production of IL-10, IL-17, and TGFβ [66]. Overall, the p47phox deficiency leads to differentiation towards the Th17 lineage. Interestingly, another study showed that CD4+ T cells from gp91phox−/− mice display the Th1 phenotype. These cells produce less IL-4 and IL-5 but more IL-17 and IFNγ than the wild-type counterparts [69]. Moreover, they have reduced GATA-3 expression and diminished STAT-5 and STAT-6 phosphorylation but increased T-bet expression [69]. The stark differences in T-bet and IFNγ expression between the two studies might be explained by the different NOX-2 subunits that have been knocked out, probably indicating that in addition to participating in the assembly of PHOX they may have other functions. However, both studies detected decreased IL-4 and increased IL-17 production in NOX-2-deficient cells, indicating conversion from the Th2 to the Th17 phenotype (Fig. 3). Interestingly, gp91phox−/− T cells have no defect in CD25 expression or IL-2 production [69]. This was confirmed by a recent study, which showed that T cells from gp91phox−/− mice have the normal expression of CD25 and CD69 and normal proliferation [65]. Thus, NOX-2 is required for proper differentiation but not for the activation of primary murine T cells. The confirmation of these findings in human T cells using shRNA or CRISPR would be helpful to understand the function of NOX-2 in humans. However, this is complicated by the low transfectability of primary T cells [70], and by oxidative stress [71] and general activation [72] that will be induced upon electroporation. The elucidation of the role of lipoxygenase- or RISP-derived ROS by the downregulation of these proteins is even more problematic, as this will additionally disturb cell metabolism.

Another approach that has been used to understand the functional importance of ROS in the activation of primary T cells is incubation with antioxidants. In murine T cells, butylated hydroxyanisole (BHA) blocks DNA synthesis and CD25 expression [73], whereas the mitochondria-targeted vitamin E (Mitovitamin E) abrogates IL-2 production [67]. In human T cells, nordihydroguaiaretic acid (NDGA) inhibits IL-2 synthesis [74], whereas vitamin E suppresses IL-4 production [75]. Interestingly, catalase, superoxide dismutase, and ascorbate do not affect the expression of CD25 and CD69, proliferation, and cytokine production in human T cells [65]. It seems that antioxidants that inhibit lipid peroxidation and/or lipoxygenase activity (such as NDGA, BHA, Vitamin E, or Mitovitamin E), but not antioxidants that scavenge water-soluble ROS (such as catalase, superoxide dismutase, or ascorbate) can interfere with the activation of primary T cells (Fig. 3). The intriguing possibility is that reduction in the synthesis of leukotrienes (proinflammatory molecules downstream of lipoxygenase), rather than reduction in ROS levels per se [76], could be the reason for the impairment of T-cell activation by lipid-soluble antioxidants. This hypothesis is in agreement with the findings that NOX-2 deficient T cells have normal CD25 and CD69 expression, IL-2 production, and proliferation [65, 69].

Collectively, it seems that ROS produced by NOX-2 are involved in the differentiation of T cells but not in the initial phase of T-cell activation. The further expansion of knowledge on the role of NOX-2 and other ROS sources in primary T-cells will result in the clinical applications. For example, it has been recently shown that T cells from patients with systemic sclerosis express elevated levels of NOX-2 and have higher basal ROS levels [77].

Conclusions and perspectives

T cells are not isolated entities and are present in various tissue microenvironments. It has become evident that the surrounding cells create a particular redox milieu that may, in turn, influence T-cell responses. For example, neutrophils in the inflamed tissues produce large amounts of ROS, which can suppress or even kill T cells. On the contrary, macrophages and dendritic cells secrete the glutathione precursor cysteine and the thiol-reducing enzyme thioredoxin, which increase the oxidation resistance of T cells. Moreover, Tregs can interfere with these processes and hence regulate T-cell activation. Additionally, appropriate intracellular ROS levels in T cells are created by the controlled production of ROS via NOX-2, DUOX-1, and mitochondria and the expression of a variety of antioxidant systems, including superoxide dismutases, peroxiredoxins, and glutaredoxins. Indeed, the available data suggest that ROS play crucial roles in T-cell biology. First, ROS participate in activation-induced cell death and hence in the termination of the immune response. Several different sources of ROS appear to be involved in this process. It seems that DUOX-1 produces H2O2 that amplifies proximal TCR signaling, mitochondrial Complex I releases O2 •- that triggers the expression of FasL, and NOX-2 generates H2O2 that assists the execution of the apoptotic program. Second, ROS appear to be involved in the differentiation of T cells but dispensable for T-cell activation or proliferation. NOX-2-derived ROS direct the differentiation of T cells from the Th17 to the Th2 phenotype, at least in mice. Overall, under physiological conditions, there is an equilibrium between ROS and antioxidants, both in the tissue microenvironment and intracellular compartments, thus allowing normal T-cell responses. However, this delicate balance is disturbed in several diseases, such as systemic sclerosis, rheumatoid arthritis, AIDS, and cancer. The better understanding of the spatiotemporal dynamics and regulation of ROS production and elimination in T cells and their microenvironment is essential for the development of more effective treatments against various immune-mediated diseases.

Despite the remarkable progress in recent years, still much remains to be discovered about the function of ROS in T-cell biology. New experimental techniques should foster considerable advances in several areas of research. To address the compartmentalized nature of signaling ROS, methods for the highly sensitive spatial real-time measurement of ROS levels in living cells are desirable. The most promising approach in this field appears to be the combination of novel photostable, specific, reversible ROS probes [78] with the high-resolution microscopy of living cells [79]. The imaging flow cytometry [80], which combines the high throughput and populational analysis capabilities of traditional flow cytometry with the spatial resolution of microscopy, may also become particularly helpful. In order to discriminate between ROS produced by T cells and phagocytes, T-cell specific knockout mice for NOX-2, DUOX-1, and other ROS-producing enzymes are indispensable. Methods to efficiently and stably downregulate these proteins in primary human T cells without inducing oxidative stress, cell death, and cell preactivation are also essential. The microfluidic [81] delivery of shRNAs or CRISPRs [82] is amongst the most promising approaches. The same technique may be applied to knockdown peroxiredoxins, the major counterbalance to NOX enzymes. To understand the role of mitochondrial ROS, the organelle-targeted antioxidants [83] seem to be almost the exclusive tool, as it is not possible to inhibit the mitochondrial ROS-producing electron transport chain without affecting mitochondrial ATP production, calcium uptake, and metabolic functions. Finally, only few molecular targets of ROS in T cells are currently known [68]. The development of simple and reliable methods to measure protein sulfenylation [84], including the probes for real-time microscopy [85], would allow to investigate this new exciting area of research.

Abbreviations

AICD: 

Activation-induced cell death

BHA: 

Butylated hydroxyanisole

CuZnSOD: 

Copper-zinc superoxide dismutase

DCs: 

Dendritic cells

DCFDA: 

Dichlorofluorescin diacetate

DHE: 

Dihydroethidium

DUOX: 

Dual oxidase

gp91phox

Phagocytic NADPH oxidase glycoprotein of 91 kDa

H2O2

Hydrogen peroxide

mito-roGFP: 

Mitochondrial reduction-oxidation sensitive green fluorescent protein

MnSOD: 

Manganese superoxide dismutase

NAC: 

N-acetyl cysteine

NOX: 

NADPH oxidase

O2 •-

Superoxide

p47phox

Phagocytic NADPH oxidase protein of 47 kDa

PRX: 

Peroxiredoxin

RISP: 

Rieske iron-sulfur protein

ROS: 

Reactive oxygen species

TCR: 

T-cell receptor

TRX: 

Thioredoxin

Declarations

Acknowledgements

This work is supported by grants of the German Research Foundation (DFG) to LS and BS (SFB854, project B19) and to LS (SPP1710, project SI861-3/1).

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Otto-von-Guericke University
(2)
Institute of Molecular and Clinical Immunology, Otto-von-Guericke University

References

  1. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol. 2008;4(5):278–86.View ArticlePubMedGoogle Scholar
  2. Miller AF. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett. 2012;586(5):585–95.View ArticlePubMedGoogle Scholar
  3. Winterbourn CC. The biological chemistry of hydrogen peroxide. Methods Enzymol. 2013;528:3–25.View ArticlePubMedGoogle Scholar
  4. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med. 2009;47(4):333–43.View ArticlePubMedGoogle Scholar
  5. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909–50.PubMed CentralView ArticlePubMedGoogle Scholar
  6. Brown GC, Borutaite V. There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion. 2012;12(1):1–4.View ArticlePubMedGoogle Scholar
  7. Hanschmann EM, Godoy JR, Berndt C, Hudemann C, Lillig CH. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal. 2013;19(13):1539–605.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol. 2013;13(5):349–61.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239–47.View ArticlePubMedGoogle Scholar
  10. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603–16.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–47.View ArticlePubMedGoogle Scholar
  12. Babior BM. The respiratory burst of phagocytes. J Clin Invest. 1984;73(3):599–601.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Quinn MT. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol. 2004;76(4):760–81.View ArticlePubMedGoogle Scholar
  14. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4(3):181–9.View ArticlePubMedGoogle Scholar
  15. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245–313.View ArticlePubMedGoogle Scholar
  16. Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol. 2011;7(8):504–11.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Holmstrom KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15(6):411–21.View ArticlePubMedGoogle Scholar
  18. Gough DR, Cotter TG. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis. 2011;2:e213.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Marino SM, Gladyshev VN. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Molecular Biol. 2010;404(5):902–16.View ArticleGoogle Scholar
  20. Garcia-Santamarina S, Boronat S, Hidalgo E. Reversible cysteine oxidation in hydrogen peroxide sensing and signal transduction. Biochemistry. 2014;53(16):2560–80.View ArticlePubMedGoogle Scholar
  21. Poole LB, Karplus PA, Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol. 2004;44:325–47.View ArticlePubMedGoogle Scholar
  22. Lo Conte M, Carroll KS. The redox biochemistry of protein sulfenylation and sulfinylation. J Biol Chem. 2013;288(37):26480–8.PubMed CentralView ArticlePubMedGoogle Scholar
  23. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007;8(10):813–24.View ArticlePubMedGoogle Scholar
  24. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med. 2009;47(9):1239–53.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Gorlach A, Klappa P, Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal. 2006;8(9–10):1391–418.View ArticlePubMedGoogle Scholar
  26. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci. 2010;35(9):505–13.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Rigoulet M, Yoboue ED, Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H (2) O (2) signaling. Antioxid Redox Signal. 2011;14(3):459–68.View ArticlePubMedGoogle Scholar
  28. Sandalio LM, Rodriguez-Serrano M, Romero-Puertas MC, del Rio LA. Role of peroxisomes as a source of reactive oxygen species (ROS) signaling molecules. Subcell Biochem. 2013;69:231–55.View ArticlePubMedGoogle Scholar
  29. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE. 2006;2006(349):re8.PubMedGoogle Scholar
  30. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal. 2009;11(6):1289–99.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Rhee SG, Kang SW, Jeong W, Chang T-S, Yang K-S, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol. 2005;17(2):183–9.View ArticlePubMedGoogle Scholar
  32. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005;38(12):1543–52.View ArticlePubMedGoogle Scholar
  33. Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009;8(24):4072–8.View ArticlePubMedGoogle Scholar
  34. Perkins A, Nelson KJ, Parsonage D, Poole LB, Karplus PA. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci. 2015;40(8):435–45.View ArticlePubMedGoogle Scholar
  35. Zhang JH, Ferrante A, Arrigo AP, Dayer JM. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J Immunol. 1992;148(1):177–81.PubMedGoogle Scholar
  36. Cemerski S, Cantagrel A, Van Meerwijk JP, Romagnoli P. Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem. 2002;277(22):19585–93.View ArticlePubMedGoogle Scholar
  37. Mougiakakos D, Johansson CC, Kiessling R. Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood. 2009;113(15):3542–5.View ArticlePubMedGoogle Scholar
  38. Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, et al. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol. 1994;153(11):4880–9.PubMedGoogle Scholar
  39. Takahashi A, Hanson MG, Norell HR, Havelka AM, Kono K, Malmberg KJ, et al. Preferential cell death of CD8+ effector memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative stress. J Immunol. 2005;174(10):6080–7.View ArticlePubMedGoogle Scholar
  40. Bogeski I, Kummerow C, Al-Ansary D, Schwarz EC, Koehler R, Kozai D, et al. Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. Sci Signal. 2010;3(115):ra24.View ArticlePubMedGoogle Scholar
  41. Gmunder H, Eck HP, Benninghoff B, Roth S, Droge W. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol. 1990;129(1):32–46.View ArticlePubMedGoogle Scholar
  42. Yan Z, Garg SK, Kipnis J, Banerjee R. Extracellular redox modulation by regulatory T cells. Nat Chem Biol. 2009;5(10):721–3.PubMed CentralView ArticlePubMedGoogle Scholar
  43. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G, et al. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A. 2002;99(3):1491–6.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Martner A, Aurelius J, Rydstrom A, Hellstrand K, Thoren FB. Redox Remodeling by Dendritic Cells Protects Antigen-Specific T Cells against Oxidative Stress. J Immunol. 2011;187(12):6243–8.View ArticlePubMedGoogle Scholar
  45. Yan Z, Garg SK, Banerjee R. Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J Biol Chem. 2010;285(53):41525–32.PubMed CentralView ArticlePubMedGoogle Scholar
  46. Mougiakakos D, Johansson CC, Jitschin R, Bottcher M, Kiessling R. Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood. 2011;117(3):857–61.View ArticlePubMedGoogle Scholar
  47. Gmunder H, Roth S, Eck HP, Gallas H, Mihm S, Droge W. Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. Cell Immunol. 1990;130(2):520–8.View ArticlePubMedGoogle Scholar
  48. Suthanthiran M, Anderson ME, Sharma VK, Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci U S A. 1990;87(9):3343–7.PubMed CentralView ArticlePubMedGoogle Scholar
  49. Smyth MJ. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J Immunol. 1991;146(6):1921–7.PubMedGoogle Scholar
  50. Gringhuis SI, der Voort EA P-v, Leow A, Nivine Levarht EW, Breedveld FC, Verweij CL. Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol Cell Biol. 2002;22(2):400–11.PubMed CentralView ArticlePubMedGoogle Scholar
  51. Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R, et al. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest. 2007;117(10):3020–8.PubMed CentralView ArticlePubMedGoogle Scholar
  52. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci U S A. 2006;103(34):12831–6.PubMed CentralView ArticlePubMedGoogle Scholar
  53. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010;70(1):68–77.PubMed CentralView ArticlePubMedGoogle Scholar
  54. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol. 2007;7(7):532–42.View ArticlePubMedGoogle Scholar
  55. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol. 2004;5(8):818–27.View ArticlePubMedGoogle Scholar
  56. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med. 2002;195(1):59–70.PubMed CentralView ArticlePubMedGoogle Scholar
  57. Kwon J, Devadas S, Williams MS. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation. Free Radic Biol Med. 2003;35(4):406–17.View ArticlePubMedGoogle Scholar
  58. Kwon J, Shatynski KE, Chen H, Morand S, de Deken X, Miot F, et al. The nonphagocytic NADPH oxidase Duox1 mediates a positive feedback loop during T cell receptor signaling. Sci Signal. 2010;3(133):ra59.PubMed CentralView ArticlePubMedGoogle Scholar
  59. Gulow K, Kaminski M, Darvas K, Suss D, Li-Weber M, Krammer PH. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J Immunol. 2005;174(9):5249–60.View ArticlePubMedGoogle Scholar
  60. Kaminski M, Kiessling M, Suss D, Krammer PH, Gulow K. Novel Role for Mitochondria: Protein Kinase C -Dependent Oxidative Signaling Organelles in Activation-Induced T-Cell Death. Mol Cell Biol. 2007;27(10):3625–39.PubMed CentralView ArticlePubMedGoogle Scholar
  61. Kaminski MM, Roth D, Sass S, Sauer SW, Krammer PH, Gulow K. Manganese superoxide dismutase: a regulator of T cell activation-induced oxidative signaling and cell death. Biochim Biophys Acta. 2012;1823(5):1041–52.View ArticlePubMedGoogle Scholar
  62. Li-Weber M, Weigand MA, Giaisi M, Suss D, Treiber MK, Baumann S, et al. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest. 2002;110(5):681–90.PubMed CentralView ArticlePubMedGoogle Scholar
  63. Pricop L, Gokhale J, Redecha P, Ng SC, Salmon JE. Reactive oxygen intermediates enhance Fc gamma receptor signaling and amplify phagocytic capacity. J Immunol. 1999;162(12):7041–8.PubMedGoogle Scholar
  64. Los M, Schenk H, Hexel K, Baeuerle PA, Droge W, Schulze-Osthoff K. IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 1995;14(15):3731–40.PubMed CentralPubMedGoogle Scholar
  65. Belikov AV, Schraven B, Simeoni L. TCR-triggered extracellular superoxide production is not required for T-cell activation. Cell Commun Signal. 2014;12:50.PubMed CentralView ArticlePubMedGoogle Scholar
  66. Tse HM, Thayer TC, Steele C, Cuda CM, Morel L, Piganelli JD, et al. NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. J Immunol. 2010;185(9):5247–58.PubMed CentralView ArticlePubMedGoogle Scholar
  67. Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013;38(2):225–36.PubMed CentralView ArticlePubMedGoogle Scholar
  68. Michalek RD, Nelson KJ, Holbrook BC, Yi JS, Stridiron D, Daniel LW, et al. The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J Immunol. 2007;179(10):6456–67.View ArticlePubMedGoogle Scholar
  69. Shatynski KE, Chen H, Kwon J, Williams MS. Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: role in T helper development. Eur J Immunol. 2012;42(12):3202–11.PubMed CentralView ArticlePubMedGoogle Scholar
  70. Ebert O, Finke S, Salahi A, Herrmann M, Trojaneck B, Lefterova P, et al. Lymphocyte apoptosis: induction by gene transfer techniques. Gene Ther. 1997;4(4):296–302.View ArticlePubMedGoogle Scholar
  71. Bonnafous P, Vernhes M, Teissie J, Gabriel B. The generation of reactive-oxygen species associated with long-lasting pulse-induced electropermeabilisation of mammalian cells is based on a non-destructive alteration of the plasma membrane. Biochim Biophys Acta. 1999;1461(1):123–34.View ArticlePubMedGoogle Scholar
  72. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel TH, et al. The impact of Nucleofection (R) on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123–31.PubMed CentralView ArticlePubMedGoogle Scholar
  73. Chaudhri G, Hunt NH, Clark IA, Ceredig R. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol. 1988;115(1):204–13.View ArticlePubMedGoogle Scholar
  74. Gerber M, Ball D, Michel F, Crastes de Paulet A. Mechanism of enhancing effect of irradiation on production of IL-2. Immunol Lett. 1985;9(5):279–83.View ArticlePubMedGoogle Scholar
  75. Li-Weber M, Giaisi M, Treiber MK, Krammer PH. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur J Immunol. 2002;32(9):2401–8.View ArticlePubMedGoogle Scholar
  76. Slapke J, Schewe T, Hummel S, Winkler J, Kopf M. Lung strips from guinea pigs as test system for lipoxygenase inhibitors. Inhibition of arachidonic acid-induced contractions by 3-t-butyl-4-hydroxyanisole and nordihydroguaiaretic acid. Biomed Biochim Acta. 1983;42(10):1309–18.PubMedGoogle Scholar
  77. Amico D, Spadoni T, Rovinelli M, Serafini M, D'Amico G, Campelli N, et al. Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2. Arthritis Res Ther. 2015;17:68.PubMed CentralView ArticlePubMedGoogle Scholar
  78. Woolley JF, Stanicka J, Cotter TG. Recent advances in reactive oxygen species measurement in biological systems. Trends Biochem Sci. 2013;38(11):556–65.View ArticlePubMedGoogle Scholar
  79. Li D, Shao L, Chen BC, Zhang X, Zhang M, Moses B, et al. ADVANCED IMAGING. Extended-resolution structured illumination imaging of endocytic and cytoskeletal dynamics. Science. 2015;349(6251):aab3500.View ArticlePubMedGoogle Scholar
  80. Cerveira J, Begum J, Di Marco BR, van der Veen AG, Filby A. An imaging flow cytometry-based approach to measuring the spatiotemporal calcium mobilisation in activated T cells. J Immunol Methods. 2015;423:120–30.View ArticlePubMedGoogle Scholar
  81. Sharei A, Trifonova R, Jhunjhunwala S, Hartoularos GC, Eyerman AT, Lytton-Jean A, et al. Ex vivo cytosolic delivery of functional macromolecules to immune cells. PLoS One. 2015;10(4):e0118803.PubMed CentralView ArticlePubMedGoogle Scholar
  82. Boettcher M, McManus MT. Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR. Mol Cell. 2015;58(4):575–85.View ArticlePubMedGoogle Scholar
  83. Smith RA, Hartley RC, Murphy MP. Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal. 2011;15(12):3021–38.View ArticlePubMedGoogle Scholar
  84. Pan J, Carroll KS. Chemical biology approaches to study protein cysteine sulfenylation. Biopolymers. 2014;101(2):165–72.PubMed CentralView ArticlePubMedGoogle Scholar
  85. Yin Q, Huang C, Zhang C, Zhu W, Xu Y, Qian X, et al. In situ visualization and detection of protein sulfenylation responses in living cells through a dimedone-based fluorescent probe. Org Biomol Chem. 2013;11(43):7566–73.View ArticlePubMedGoogle Scholar

Copyright

© Belikov et al. 2015

Advertisement